These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8639055)

  • 1. Expression of bcl-2 in uveal malignant melanoma.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
    Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
    Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T1799A point mutation is present in posterior uveal melanoma.
    Janssen CS; Sibbett R; Henriquez FL; McKay IC; Kemp EG; Roberts F
    Br J Cancer; 2008 Nov; 99(10):1673-7. PubMed ID: 18985043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma.
    Ehlers JP; Worley L; Onken MD; Harbour JW
    Clin Cancer Res; 2005 May; 11(10):3609-13. PubMed ID: 15897555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic investigations of posterior uveal melanoma.
    Hovland PG; Trempe C
    Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma.
    Sisley K; Parsons MA; Garnham J; Potter AM; Curtis D; Rees RC; Rennie IG
    Br J Cancer; 2000 Jan; 82(2):330-8. PubMed ID: 10646885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
    Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
    Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered chromosome expression of uveal melanoma in the setting of melanocytosis.
    Horgan N; Shields CL; Swanson L; Teixeira LF; Eagle RC; Ganguly A; Shields JA
    Acta Ophthalmol; 2009 Aug; 87(5):578-80. PubMed ID: 18547285
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.
    Smith SL; Damato BE; Scholes AG; Nunn J; Field JK; Heighway J
    Br J Cancer; 2002 Nov; 87(11):1308-13. PubMed ID: 12439722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
    Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
    Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
    Krvavica A; Talan-Hranilović J; Belicza M
    Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas.
    Pópulo H; Vinagre J; Lopes JM; Soares P
    Br J Ophthalmol; 2011 May; 95(5):715-9. PubMed ID: 20805136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
    Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
    Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
    Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic profile of uveal melanoma.
    Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
    Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
    Filer RS; Song JC; Char DH; Kaleta-Michaels S
    Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 expression in uveal malignant melanomas.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.